Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ziyedan (紫叶丹) is a traditional Chinese herbal medicine formulation, primarily available as a capsule. It is used for the treatment of chronic hepatitis B and has also been approved in China for the management of flank pain. The main active ingredient or herbal basis appears to be "Zizhu" (紫珠), though detailed composition information is not provided in the available sources. Clinical studies have focused on its efficacy and safety in improving viral response, serological markers, biochemical indices, and clinical symptoms in patients with chronic hepatitis B[1][2][3]. The mechanism of action has not been clearly elucidated or specified in public sources; as an herbal medicine, it may exert multi-target effects typical of traditional Chinese medicinal products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ziyedan.